The theme for World Malaria Day 2023 is "End Malaria for Good", with a focus on accelerating progress towards the global goal of eliminating malaria by 2030. This will require sustained efforts to expand access to malaria prevention, diagnosis, and treatment, as well as ongoing research and innovation to develop new tools and strategies to fight the disease.
01 Overview of Malaria
According to the report of the World Health Organization, about 40% of the world's population is threatened by malaria. Every year, 350 million to 500 million people are infected with malaria, 1.1 million people die from malaria, and 3,000 children die from malaria every day. The incidence is mainly concentrated in areas with relatively backward economy. For approximately one in two people worldwide, malaria remains by far one of the most serious threats to public health.
02 How Malaria Spreads
1. Mosquito-borne transmission
The main vector of malaria is the Anopheles mosquito. It is mainly prevalent in the tropics and subtropics, and the incidence is more frequent in summer and autumn in most areas.
2. Blood transmission
People can become infected with malaria by transfusion of blood infected with Plasmodium parasites. Congenital malaria can also be caused by damage to the placenta or infection of fetal wounds by malarial or malaria-carrying maternal blood during delivery.
In addition, people in non-malaria-endemic areas have weak resistance to malaria. Malaria is easily transmitted when patients or carriers from endemic areas enter non-endemic areas.
03 Clinical manifestations of malaria
There are four types of Plasmodium that parasitize the human body, they are Plasmodium vivax, Plasmodium falciparum, Plasmodium malariae and Plasmodium ovale. The main symptoms after malaria infection include periodic chills, fever, sweating, etc., sometimes accompanied by headache, nausea, diarrhea, and coughing. Patients with severe conditions may also experience delirium, coma, shock, and liver and kidney failure. If they are not treated in time, they may be life-threatening due to delayed treatment.
04 How to Prevent and Control Malaria
1. Malaria infection should be treated in time. The commonly used drugs are chloroquine and primaquine. Artemether and dihydroartemisinin are more effective in treating falciparum malaria.
2. In addition to drug prevention, it is also necessary to take measures to prevent and eliminate mosquitoes to reduce the risk of malaria infection from the root.
3. Improve the malaria detection system and treat the infected in time to prevent the spread of malaria.
05 Solution
Macro & Micro-Test has developed a series of detection kits for malaria detection, which can be applied to immunochromatography detection platform, fluorescent PCR detection platform and isothermal amplification detection platform. We provide holistic and comprehensive solutions for the diagnosis, treatment monitoring and prognosis of Plasmodium infection:
Immunochromatography Platform
l Plasmodium Falciparum/Plasmodium Vivax Antigen Detection Kit(Colloidal Gold)
l Plasmodium Falciparum Antigen Detection Kit (Colloidal Gold )
l Plasmodium Antigen Detection Kit(Colloidal Gold）
This kit is intended for in vitro qualitative detection and identification of Plasmodium falciparum (P.f.), Plasmodium vivax (P.v.), Plasmodium ovale (P.o.) or Plasmodium malaria (P.m.) in venous blood or capillary blood of people with symptoms and signs of malaria protozoa, which can assist in the diagnosis of Plasmodium infection.
· Easy to use: Only 3 steps
· Room temperature: Transportation & storage at 4-30°C for 24 months
· Accuracy: High sensitivity& specificity
Fluorescent PCR Platform
l Plasmodium Nucleic Acid Detection Kit(Fluorescence PCR)
l Freeze-dried Plasmodium Nucleic Acid Detection Kit (Fluorescence PCR)
This kit is used for in vitro qualitative detection of Plasmodium nucleic acid in peripheral blood samples of patients with suspected Plasmodium infection.
· Internal control: Fully monitor the experimental process to ensure the quality of the experiment
· High specificity: No cross-reactivity with common respiratory pathogens for more accurate results
· High sensitivity: 5 Copies/μL
Isothermal Amplification Platform
l Nucleic Acid Detection Kit based on Enzymatic Probe Isothermal Amplification (EPIA) for Plasmodium
This kit is used for in vitro qualitative detection of malaria parasite nucleic acid in peripheral blood samples of patients suspected of plasmodium infection.
· Internal control: Fully monitor the experimental process to ensure the quality of the experiment
· High specificity: No cross-reactivity with common respiratory pathogens for more accurate results
· High sensitivity: 5 Copies/μL
|
Catalogue Number |
Product Name |
Specification |
|
HWTS-OT055A/B |
Plasmodium Falciparum/Plasmodium Vivax Antigen Detection Kit(Colloidal Gold) |
1 test/kit，20 tests/kit |
|
HWTS-OT056A/B |
Plasmodium Falciparum Antigen Detection Kit (Colloidal Gold ) |
1test/kit，20 tests/kit |
|
HWTS-OT057A/B |
Plasmodium Antigen Detection Kit(Colloidal Gold） |
1test/kit，20 tests/kit |
|
HWTS-OT054A/B/C |
Freeze-dried Plasmodium Nucleic Acid Detection Kit (Fluorescence PCR) |
20 tests/kit，50 tests/kit，48 tests/kit |
|
HWTS-OT074A/B |
Plasmodium Nucleic Acid Detection Kit(Fluorescence PCR) |
20 tests/kit，50 tests/kit |
|
HWTS-OT033A/B |
Nucleic Acid Detection Kit based on Enzymatic Probe Isothermal Amplification (EPIA) for Plasmodium |
50 tests/kit，16 tests/kit |
Post time: Apr-25-2023